MHRA approves Marinus Pharmaceuticals’ Ztalmy for CDKL5 deficiency disorder
The rare epileptic seizure disorder currently affects around one in 42,000 people in the UK
Read More
Tag: ganaxolone
- Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
- Royal Marsden launches first UK genome testing facility to improve testing for cancer
- Sysmex receives Longitude Prize on AMR for antimicrobial testing system
- LifeArc funds new projects to address and prevent global threat of dengue fever
- New study reveals how brain cell communication is linked to Alzheimer’s disease
